Results 91 to 100 of about 136 (106)

Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method

International Journal of Molecular Sciences, 2022
Rolf Teschke, Nahum Mendez-Sanchez
exaly  

Polygenic architecture informs potential vulnerability to drug-induced liver injury

Nature Medicine, 2020
Masaru Koido, Momoko Ohori, Guruprasad P Aithal   +2 more
exaly  

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes

Archives of Toxicology, 2021
Guillermo QuintÁs, Eugenia Pareja Ibars, Jos Kleinjans   +2 more
exaly  

The changing epidemiology of liver diseases in the Asia–Pacific region

Nature Reviews Gastroenterology and Hepatology, 2018
Jacob George, Junjie Huang, Colette Leung   +2 more
exaly  

Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI)

Molecular Pharmaceutics, 2020
Daniel H Foil, Sean Ekins
exaly  

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

Nature Reviews Drug Discovery, 2019
Richard J Weaver, Amy E Chadwick, Ian M Copple   +2 more
exaly  

Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis

Medicines (Basel, Switzerland), 2020
Rolf Teschke, Gaby Danan
exaly  

Drug-induced liver injury

Nature Reviews Disease Primers, 2019
Naga Chalasani, Einar S Björnsson, Ayako Suzuki   +2 more
exaly  

Landscape of DILI-related adverse drug reaction in China Mainland

Acta Pharmaceutica Sinica B, 2022
exaly  

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Archives of Toxicology, 2019
Franziska Kappenberg, Tim Brecklinghaus, Marcel Leist   +2 more
exaly